Biocon Limited — Financials & Forensics
Sector: Healthcare · NSE: BIOCON · BSE: 532523 · ISIN: INE376G01013
11 Sep 2026
Add BIOCON to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹8,184 Cr | ₹11,174 Cr | ₹14,756 Cr | ₹15,262 Cr | ₹16,927 Cr |
| EBITDA | ₹1,970 Cr | ₹2,512 Cr | ₹3,299 Cr | ₹3,166 Cr | ₹3,455 Cr |
| EBITDA margin | 24.1% | 22.5% | 22.4% | 20.8% | 20.4% |
| Profit after tax | ₹648 Cr | ₹463 Cr | ₹1,022 Cr | ₹1,429 Cr | ₹369 Cr |
Deeper analysis
Recent filings by Biocon Limited
-
Investor Presentation
06 Aug 2026 · Financial Results
-
Monitoring Agency Report
05 Aug 2026 · Regulatory Compliance
-
Press Release
05 Aug 2026 · Financial Results
-
Outcome of Board Meeting
05 Aug 2026 · Financial Results
Never miss a filing again
About Biocon Limited on Indian Stock Alerts
Indian Stock Alerts tracks Biocon Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.